NCT00004147 - COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors | Biotech Hunter

Timeline

Start Date

July 31, 2000

Study Completion Date

November 30, 2006

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

incyclinide

Trial Locations (9)

Emory University Hospital - Atlanta, Atlanta

Henry Ford Hospital, Detroit

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

Massachusetts General Hospital Cancer Center, Boston

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

University of Pennsylvania Cancer Center, Philadelphia

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

New Approaches to Brain Tumor Therapy Consortium

OTHER